Back to top
more

Capricor Therapeutics (CAPR)

(Delayed Data from NSDQ)

$28.38 USD

28.38
3,094,982

+0.43 (1.54%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $28.69 +0.31 (1.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth A Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (175 out of 247)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Illumina (ILMN) Inks Deal to Develop Distributable Test Kits

by Zacks Equity Research

Illumina (ILMN) aims to expand access to genomic-based testing and improve patient outcome through the new partnership deal.

Zacks Equity Research

FDA Nods to Medtronic's (MDT) New Age Evolut PRO+ TAVR

by Zacks Equity Research

This latest FDA approval of Medtronic's (MDT) Evolut PRO+ follows the last month's nod from the regulatory body for the Evolut TAVR system with regard to expanded indication.

Zacks Equity Research

Insulet Receives FDA Approval for ACE Pump Implementation

by Zacks Equity Research

FDA's approval will enable Insulet (PODD) to boost its insulin management business.

Zacks Equity Research

Bruker (BRKR) Enters Into Alliance With Murdoch University

by Zacks Equity Research

Bruker's (BRKR) collaboration with Murdoch University will support International Centre of Excellence in metabolic phenotyping.

Zacks Equity Research

Neogen Forms Partnership With IGS to Enhance Beef Profile

by Zacks Equity Research

Neogen (NEOG), through the IGS partnership, aims to help cattle producers choose better cattle and enhance their productivity.

Zacks Equity Research

Medtronic Receives European Nod for Glucose Monitoring System

by Zacks Equity Research

Medtronic (MDT) plans to upgrade diabetes care by combining technical advancement with better user experience.

Zacks Equity Research

Abbott Partners With Sanofi to Upgrade Diabetes Management

by Zacks Equity Research

Abbott (ABT) collaborates with Sanofi to revolutionize diabetes care through technological advancements.

Zacks Equity Research

Baxter's (BAX) Cheetah Acquisition to Aid Patient Monitoring

by Zacks Equity Research

Baxter (BAX) expects this deal to remain neutral to its earnings in 2019 and 2020.

Zacks Equity Research

Neogen Gets AOAC Validation for NeoSeek to Ensure Food Safety

by Zacks Equity Research

Neogen's (NEOG) proprietary testing platform gets upgraded to reduce the incidence of bacterial contamination in livestock.

Zacks Equity Research

NuVasive's New TLIF Implant Broadens Spine Surgery Option

by Zacks Equity Research

NuVasive's (NUVA) Modulus TLIF-A is designed to work smoothly with the existing MAS TLIF and MAS Midline access systems.